Latest News
27-Aug-2025 Drug, Med Tech Cos Fear GST Changes May Squeeze Funds
26-Aug-2025 GSK India Makes a Comeback in Oncology
21-Aug-2025 Stricter Shelf Life Rule a Bitter Pill to Swallow for Pharma Cos
21-Aug-2025 Natco Sues Novo in Generic Drug Push...
20-Aug-2025 Aurobindo Closing in on $5.5b Zentiva Buyout
  more...
Latest Reports
Aug-25 IPM: 7% value and 2% unit decline in Jul-25 - HDFC Securities  
Jul-25 Jun-25: IPM rebounds; Glenmark shining - Nuvama  
Jul-25 1QFY26 Preview: gRevlimid pricing pressures + late IPM surge - Emkay Research  
Jul-25 IPM: 11.5% value and 5% unit growth in Jun’25 - HDFC Securities  
Jul-25 Weighty opportunity: Indian CDMOs embracing GLP-1 fill-finish - ICICI Securities  
  more...

Quarterly Summary March-2025
Desc Current Previous Per.Chg
Sales 29848.7 26038.6 14.6
Otherincome 1172.6 1168.1 0.4
Expense 22400.1 20728.5 8.1
RawMaterial 7428.0 6893.5 7.8
StaffCost 4279.7 3940.9 8.6
ExciseDuty 19.9 13.3 49.6
OtherExp 7136.3 6659.6 7.2
Interest 270.9 202.9 33.5
GrossProfit 9016.7 6956.6 29.6
Depreciation 1165.2 1182.3 -1.4
Tax 1674.7 1362.7 22.9
NetProfit 6581.1 4343.9 51.5
Total.Comp 45 -- --
Source: ETIG Database

Sectoral Companies As on 29 Aug 2025
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 382460.42
Divi's Lab 162411.60
Cipla 128403.98
Torrent Phar 120445.72
Dr.Reddy's 105409.98
Mankind Phar 101996.74
Zydus Life 98693.13
Lupin 86467.34
Abbott (I) 66932.61
Alkem Labora 63390.79
Aurobindo Ph 60212.94
Glenmark Pha 54302.34
GlaxoSmith.P 47154.43
  click here for the complete list